These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17630466)

  • 1. DALYs and QALYs in developing countries.
    Zarate V
    Health Aff (Millwood); 2007; 26(4):1197-8. PubMed ID: 17630466
    [No Abstract]   [Full Text] [Related]  

  • 2. Can we prevent cardiovascular diseases in low- and middle-income countries?
    Lenfant C
    Bull World Health Organ; 2001; 79(10):980-2; discussion 983-7. PubMed ID: 11693981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease and the UN Millennium Development Goals: time to move forward.
    Fuster V; Vedanthan R
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):593. PubMed ID: 18813335
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular disease in the developing world and its cost-effective management.
    Gaziano TA
    Circulation; 2005 Dec; 112(23):3547-53. PubMed ID: 16330695
    [No Abstract]   [Full Text] [Related]  

  • 5. Reducing the growing burden of cardiovascular disease in the developing world.
    Gaziano TA
    Health Aff (Millwood); 2007; 26(1):13-24. PubMed ID: 17211010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is inequality at the heart of it? Cross-country associations of income inequality with cardiovascular diseases and risk factors.
    Kim D; Kawachi I; Hoorn SV; Ezzati M
    Soc Sci Med; 2008 Apr; 66(8):1719-32. PubMed ID: 18280021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk.
    Murray CJ; Lauer JA; Hutubessy RC; Niessen L; Tomijima N; Rodgers A; Lawes CM; Evans DB
    Lancet; 2003 Mar; 361(9359):717-25. PubMed ID: 12620735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke and cardiovascular diseases: the need for a global approach for prevention and drug development.
    Hilbrich L; Truelsen T; Yusuf S
    Int J Stroke; 2007 May; 2(2):104-8. PubMed ID: 18705961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease in low- and middle-income countries: an urgent priority.
    Wurie HR; Cappuccio FP
    Ethn Health; 2012; 17(6):543-50. PubMed ID: 23534502
    [No Abstract]   [Full Text] [Related]  

  • 10. The cost effectiveness of preventing cardiovascular diseases.
    Grover SA
    Can J Cardiol; 1999 Dec; 15 Suppl G():114G-6G. PubMed ID: 10692671
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress and challenges in the fight against smoking and cardiovascular disease.
    Murray CJ; Roth G
    Eur Heart J; 2014 Jul; 35(25):1625-7. PubMed ID: 24986418
    [No Abstract]   [Full Text] [Related]  

  • 12. Dietary salt reduction and cardiovascular disease.
    Nair M; Prabhakaran D
    Natl Med J India; 2010; 23(6):352-3. PubMed ID: 21561048
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece.
    Gourzoulidis G; Tzanetakos C; Ioannidis I; Tsapas A; Kourlaba G; Papageorgiou G; Maniadakis N
    Clin Drug Investig; 2018 May; 38(5):417-426. PubMed ID: 29349708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QALYs in cost-effectiveness analysis: an overview for cardiologists.
    Wouters OJ; Naci H; Samani NJ
    Heart; 2015 Dec; 101(23):1868-73. PubMed ID: 26395316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between health system development and the burden of cardiovascular disease: an analysis of WHO country profiles.
    Liu Y; Dalal K; Stollenwerk B
    PLoS One; 2013; 8(4):e61718. PubMed ID: 23637891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings.
    Mendis S; Lindholm LH; Anderson SG; Alwan A; Koju R; Onwubere BJ; Kayani AM; Abeysinghe N; Duneas A; Tabagari S; Fan W; Sarraf-Zadegan N; Nordet P; Whitworth J; Heagerty A
    J Clin Epidemiol; 2011 Dec; 64(12):1451-62. PubMed ID: 21530172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risk and income].
    Escobar C; Divisón JA; Seguí Díaz M
    Semergen; 2015 Apr; 41(3):168-9. PubMed ID: 25435261
    [No Abstract]   [Full Text] [Related]  

  • 18. Global cost-effectiveness of cataract surgery.
    Lansingh VC; Carter MJ; Martens M
    Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac rehabilitation in low- and middle-income countries: a review on cost and cost-effectiveness.
    Oldridge NB; Pakosh MT; Thomas RJ
    Int Health; 2016 Mar; 8(2):77-82. PubMed ID: 26208507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs.
    Lim SS; Gaziano TA; Gakidou E; Reddy KS; Farzadfar F; Lozano R; Rodgers A
    Lancet; 2007 Dec; 370(9604):2054-62. PubMed ID: 18063025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.